Skip to main content
Caplight Logo









Moebius Medical

Moebius Medical

Private
Tel AvivHealthcare & Life Scienceshttps://moebiusmedical.com/

Last Round

Corporate Funding

Dec 12, 2016

Total Funding Raised

$100,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Moebius Medical is a drug discovery company that develops novel treatments for osteoarthritis (OA).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales

AI Layer

Non-AI

Keywords

osteoarthritis treatmentliposomal technologynon-opioid pain reliefknee osteoarthritisintra-articular injectionbiolubricationclinical-stage biotechnologyhyaluronic acid alternativecorticosteroid alternativeknee injectiondrug licensingPhase 3 clinical trialjoint lubricationFDA Fast Trackcartilage repairviscosupplementation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Moebius Medical Comparables

Compare Moebius Medical with similar companies based on industry and business-model similarity.

Moebius Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eupraxia Pharmaceuticals Inc.
79%
Lubris BioPharma
78%
Levicept
77%

Moebius Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingDec 12, 2016
AcceleratorSep 1, 2008
SeedAug 1, 2008

Key People

Founding team and executive leadership

Moshe Weinstein

CEO & Board Member

Executive Team

Yonatan Cohavi

Chief Financial Officer

Executive Team

Moebius Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 3118% MoM, reaching 5.9K.

  • Apr 16, 2026

    Monthly visitors grew 286% MoM, from 383 to 1.5K.

Recent news

Latest coverage and updates

  • recognized_asJun 15, 2026

    Moebius Medical recognized as USFDA Fast Track designation for MM-II on Jun 15th '26.

Moebius Medical Filings

Explore SEC and related filing metadata, where available.

Moebius Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Moebius Medical's valuation, stock price, and market status.

Is Moebius Medical a public or private company?

Moebius Medical is a private company.

What is the current stock price of Moebius Medical?

Moebius Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Moebius Medical worth (valuation)?

Valuation information for Moebius Medical is not publicly available.

Can I buy Moebius Medical stock?

Moebius Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Moebius Medical's last funding round?

Moebius Medical's most recent funding round was Corporate Funding on December 12, 2016.

Who are the main investors in Moebius Medical?

Key investors in Moebius Medical include RAD BioMed.

Will Moebius Medical IPO soon?

No public IPO plans have been announced for Moebius Medical.

How can I track Moebius Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Moebius Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range5
Year Founded2008
Last FundingDec 12, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?